XML 116 R66.htm IDEA: XBRL DOCUMENT v3.22.0.1
SHARE BASED COMPENSATION - Narrative (Details)
12 Months Ended
Feb. 12, 2021
contingentStockRight
shares
Mar. 09, 2020
USD ($)
contingentStockRight
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
contingentStockRight
shares
Apr. 06, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of common stock issued per CSR (in shares)         1.2082
Effective exchange ratio of Foamix ordinary shares into Menlo common stock         1.8006
Additional paid in capital reclassified to derivate liabilities       $ 975,000  
Weighted average remaining contractual term of outstanding options     7 years    
Weighted average remaining contractual term of exercisable options     5 years 6 months    
Unrecognized share based compensation expense, options     $ 6,400,000    
Aggregate intrinsic value of options outstanding     0    
Aggregate intrinsic value of exercisable options     0    
Foamix          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of contingent stock rights issued (in CSR) | contingentStockRight   1      
RSU          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Fair value of options and RSUs granted     $ 9,400,000 11,900,000  
Share-based payment cost not yet recognized, weighted average period of recognition (in years)     2 years 3 months 7 days    
Unrecognized share-based compensation cost     $ 5,600,000    
Options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Share-based payment cost not yet recognized, weighted average period of recognition (in years)     2 years 3 months 18 days    
Employees and consultants | Foamix          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Incremental compensation costs incurred     $ 1,800,000 $ 11,800,000  
Incremental compensation costs incurred     $ 900,000    
Incremental compensation costs, recognition period     1 year    
No longer employed or providing services | Foamix          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Incremental compensation costs incurred   $ 600,000 $ 1,000,000    
Additional paid in capital reclassified to derivate liabilities   $ 1,600,000      
Common stock | Foamix          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of contingent stock rights issued (in CSR) | contingentStockRight   1      
Common stock | Foamix          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares issued during the period (in shares) | shares     71,890 61,031  
2019 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares reserved for future issuance (in shares) | shares     979,795    
2018 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares reserved for future issuance (in shares) | shares     147,550    
ESPP          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares reserved for future issuance (in shares) | shares     2,232,207    
Percentage of fair market value used as purchase price   85.00%      
Percent of annual earnings that may be used to purchase shares   15.00%      
ESPP | Common stock | Foamix          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock issued during the period, conversation units (in shares) | shares 9,038     36,155  
Number of contingent stock rights issued (in CSR) | contingentStockRight 1     1  
ESPP | Common stock | Menlo | Employees and consultants          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock issued during the period, conversation units (in shares) | shares     38,716